Multiple sampling and SAF-fixative triple-faeces testing for dysbiosis and pathogenic infections of the gastrointestinal tract: Case report

Johanna Mauss, Michelle Retz, Roger Dilts, Jeffrey Langland

Research output: Contribution to journalArticle

Abstract

The classic presentation of acute gastrointestinal (GI) parasitic infection including fever, diarrhea, nausea, and/or abdominal pain is not always a reliable measure. In these cases, parasitic infections require sensitive stool testing to be identified and treated effectively. The standard practice for stool analysis typically requires 3 separate stool specimens to be collected on 3 separate days to overcome the possibility of misdiagnosis due to intermittent shedding. Nonetheless, this practice is not often utilized due to very short periods of sample viability, which often leads to patient misdiagnosis. In this study, a patient with a history that eluded to possible acute GI parasitic infection, but without classic symptomology, was screened using a sodium acetate acetic acid formalin (SAF)-fixative triple-faeces test. Even though the patient’s symptoms did not strongly suggest stool analysis, her history of travel was clinically relevant. The faeces test revealed the patient was positive for Blastocystis hominis, Dientamoeba fragilis trophs, Endolimax nana trophs, Entamoeba coli trophs, a-hemolytic Streptococcus, Enterobacter cloacae, Klebsiella pneumoniae, and yeast. Subsequently, the patient was treated for GI infection and received significant symptom relief. This case supports the concept that physicians should fully evaluate a patient’s clinical presentation and symptomology, including history and environmental exposures, and include highly sensitive testing for proper evaluation of potential GI parasitic infections.

Original languageEnglish (US)
Pages (from-to)52-54
Number of pages3
JournalAlternative Therapies in Health and Medicine
Volume24
Issue number3
StatePublished - May 1 2018

Fingerprint

Dysbiosis
Sodium Acetate
Fixatives
Feces
Acetic Acid
Formaldehyde
Gastrointestinal Tract
Parasitic Diseases
Infection
Diagnostic Errors
Dientamoeba
Endolimax
Blastocystis hominis
History
Entamoeba
Enterobacter cloacae
Environmental Exposure
Klebsiella pneumoniae
Streptococcus
Nausea

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

Multiple sampling and SAF-fixative triple-faeces testing for dysbiosis and pathogenic infections of the gastrointestinal tract : Case report. / Mauss, Johanna; Retz, Michelle; Dilts, Roger; Langland, Jeffrey.

In: Alternative Therapies in Health and Medicine, Vol. 24, No. 3, 01.05.2018, p. 52-54.

Research output: Contribution to journalArticle

@article{bc07deded1e248ac9100fd167abeac02,
title = "Multiple sampling and SAF-fixative triple-faeces testing for dysbiosis and pathogenic infections of the gastrointestinal tract: Case report",
abstract = "The classic presentation of acute gastrointestinal (GI) parasitic infection including fever, diarrhea, nausea, and/or abdominal pain is not always a reliable measure. In these cases, parasitic infections require sensitive stool testing to be identified and treated effectively. The standard practice for stool analysis typically requires 3 separate stool specimens to be collected on 3 separate days to overcome the possibility of misdiagnosis due to intermittent shedding. Nonetheless, this practice is not often utilized due to very short periods of sample viability, which often leads to patient misdiagnosis. In this study, a patient with a history that eluded to possible acute GI parasitic infection, but without classic symptomology, was screened using a sodium acetate acetic acid formalin (SAF)-fixative triple-faeces test. Even though the patient’s symptoms did not strongly suggest stool analysis, her history of travel was clinically relevant. The faeces test revealed the patient was positive for Blastocystis hominis, Dientamoeba fragilis trophs, Endolimax nana trophs, Entamoeba coli trophs, a-hemolytic Streptococcus, Enterobacter cloacae, Klebsiella pneumoniae, and yeast. Subsequently, the patient was treated for GI infection and received significant symptom relief. This case supports the concept that physicians should fully evaluate a patient’s clinical presentation and symptomology, including history and environmental exposures, and include highly sensitive testing for proper evaluation of potential GI parasitic infections.",
author = "Johanna Mauss and Michelle Retz and Roger Dilts and Jeffrey Langland",
year = "2018",
month = "5",
day = "1",
language = "English (US)",
volume = "24",
pages = "52--54",
journal = "Alternative Therapies in Health and Medicine",
issn = "1078-6791",
publisher = "InnoVision Communications",
number = "3",

}

TY - JOUR

T1 - Multiple sampling and SAF-fixative triple-faeces testing for dysbiosis and pathogenic infections of the gastrointestinal tract

T2 - Case report

AU - Mauss, Johanna

AU - Retz, Michelle

AU - Dilts, Roger

AU - Langland, Jeffrey

PY - 2018/5/1

Y1 - 2018/5/1

N2 - The classic presentation of acute gastrointestinal (GI) parasitic infection including fever, diarrhea, nausea, and/or abdominal pain is not always a reliable measure. In these cases, parasitic infections require sensitive stool testing to be identified and treated effectively. The standard practice for stool analysis typically requires 3 separate stool specimens to be collected on 3 separate days to overcome the possibility of misdiagnosis due to intermittent shedding. Nonetheless, this practice is not often utilized due to very short periods of sample viability, which often leads to patient misdiagnosis. In this study, a patient with a history that eluded to possible acute GI parasitic infection, but without classic symptomology, was screened using a sodium acetate acetic acid formalin (SAF)-fixative triple-faeces test. Even though the patient’s symptoms did not strongly suggest stool analysis, her history of travel was clinically relevant. The faeces test revealed the patient was positive for Blastocystis hominis, Dientamoeba fragilis trophs, Endolimax nana trophs, Entamoeba coli trophs, a-hemolytic Streptococcus, Enterobacter cloacae, Klebsiella pneumoniae, and yeast. Subsequently, the patient was treated for GI infection and received significant symptom relief. This case supports the concept that physicians should fully evaluate a patient’s clinical presentation and symptomology, including history and environmental exposures, and include highly sensitive testing for proper evaluation of potential GI parasitic infections.

AB - The classic presentation of acute gastrointestinal (GI) parasitic infection including fever, diarrhea, nausea, and/or abdominal pain is not always a reliable measure. In these cases, parasitic infections require sensitive stool testing to be identified and treated effectively. The standard practice for stool analysis typically requires 3 separate stool specimens to be collected on 3 separate days to overcome the possibility of misdiagnosis due to intermittent shedding. Nonetheless, this practice is not often utilized due to very short periods of sample viability, which often leads to patient misdiagnosis. In this study, a patient with a history that eluded to possible acute GI parasitic infection, but without classic symptomology, was screened using a sodium acetate acetic acid formalin (SAF)-fixative triple-faeces test. Even though the patient’s symptoms did not strongly suggest stool analysis, her history of travel was clinically relevant. The faeces test revealed the patient was positive for Blastocystis hominis, Dientamoeba fragilis trophs, Endolimax nana trophs, Entamoeba coli trophs, a-hemolytic Streptococcus, Enterobacter cloacae, Klebsiella pneumoniae, and yeast. Subsequently, the patient was treated for GI infection and received significant symptom relief. This case supports the concept that physicians should fully evaluate a patient’s clinical presentation and symptomology, including history and environmental exposures, and include highly sensitive testing for proper evaluation of potential GI parasitic infections.

UR - http://www.scopus.com/inward/record.url?scp=85052624152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052624152&partnerID=8YFLogxK

M3 - Article

C2 - 29055284

AN - SCOPUS:85052624152

VL - 24

SP - 52

EP - 54

JO - Alternative Therapies in Health and Medicine

JF - Alternative Therapies in Health and Medicine

SN - 1078-6791

IS - 3

ER -